DNA methylation signatures of breast cancer in peripheral T-cells

37Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Immune surveillance acts as a defense mechanism in cancer, and its disruption is involved in cancer progression. DNA methylation reflects the phenotypic identity of cells and recent data suggested that DNA methylation profiles of T cells and peripheral blood mononuclear cells (PBMC) are altered in cancer progression. Methods: We enrolled 19 females with stage 1 and 2, nine with stage 3 and 4 and 9 age matched healthy women. T cells were isolated from peripheral blood and extracted DNA was subjected to Illumina 450 K DNA methylation array analysis. Raw data was analyzed by BMIQ, ChAMP and ComBat followed by validation of identified genes by pyrosequencing. Results: Analysis of data revealed ~10,000 sites that correlated with breast cancer progression and established a list of 89 CG sites that were highly correlated (p<0.01, r>0.7, r

Cite

CITATION STYLE

APA

Parashar, S., Cheishvili, D., Mahmood, N., Arakelian, A., Tanvir, I., Khan, H. A., … Rabbani, S. A. (2018). DNA methylation signatures of breast cancer in peripheral T-cells. BMC Cancer, 18(1). https://doi.org/10.1186/s12885-018-4482-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free